The cellular immunotherapy of cancer: Current and potential uses of interleukin-2

Paul M. Sondel; Jacquelyn A. Hank; Peter C. Kohler; Jeff A. Sosman; Gilda Weil-Hillman; Paul Fisch; Fritz H. Bach

doi:10.1016/S1040-8428(89)80008-3

The cellular immunotherapy of cancer: Current and potential uses of interleukin-2

Paul M. Sondel^*, Jacquelyn A. Hank, Peter C. Kohler, Jeff A. Sosman, Gilda Weil-Hillman, Paul Fisch, Fritz H. Bach

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Original language	English (US)
Pages (from-to)	125-147
Number of pages	23
Journal	Critical Reviews in Oncology and Hematology
Volume	9
Issue number	2
DOIs	https://doi.org/10.1016/S1040-8428(89)80008-3
State	Published - 1989

ASJC Scopus subject areas

Hematology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1040-8428(89)80008-3

Cite this

@article{3d54eb78778c44d7bac0edd39405d2ff,

title = "The cellular immunotherapy of cancer: Current and potential uses of interleukin-2",

author = "Sondel, {Paul M.} and Hank, {Jacquelyn A.} and Kohler, {Peter C.} and Sosman, {Jeff A.} and Gilda Weil-Hillman and Paul Fisch and Bach, {Fritz H.}",

note = "Funding Information: The authors thank Drs. R. Hong, P. P. Carbone, E. C. Borden, and B. Storer for their support and collaborative efforts, K. Moore, R. N. for excellent patient care, D. Meltzer, K. Zaremba, C. Nobis, D. Wondrash, and N. Miller for technical and administrative assistance, and M. Pankratz for preparation of this manuscript. This research was supported by NIH contract CM-47669, NIH grants CA-32685 and RR-03186, American Cancer Society grant CH-237B, and a research fellowship of the Leukemia Society of America (P. Fisch).",

year = "1989",

doi = "10.1016/S1040-8428(89)80008-3",

language = "English (US)",

volume = "9",

pages = "125--147",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - The cellular immunotherapy of cancer

T2 - Current and potential uses of interleukin-2

AU - Sondel, Paul M.

AU - Hank, Jacquelyn A.

AU - Kohler, Peter C.

AU - Sosman, Jeff A.

AU - Weil-Hillman, Gilda

AU - Fisch, Paul

AU - Bach, Fritz H.

N1 - Funding Information: The authors thank Drs. R. Hong, P. P. Carbone, E. C. Borden, and B. Storer for their support and collaborative efforts, K. Moore, R. N. for excellent patient care, D. Meltzer, K. Zaremba, C. Nobis, D. Wondrash, and N. Miller for technical and administrative assistance, and M. Pankratz for preparation of this manuscript. This research was supported by NIH contract CM-47669, NIH grants CA-32685 and RR-03186, American Cancer Society grant CH-237B, and a research fellowship of the Leukemia Society of America (P. Fisch).

PY - 1989

Y1 - 1989

UR - http://www.scopus.com/inward/record.url?scp=0024353384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024353384&partnerID=8YFLogxK

U2 - 10.1016/S1040-8428(89)80008-3

DO - 10.1016/S1040-8428(89)80008-3

M3 - Article

C2 - 2663205

AN - SCOPUS:0024353384

VL - 9

SP - 125

EP - 147

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 2

ER -

The cellular immunotherapy of cancer: Current and potential uses of interleukin-2

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this